Preferred Label : niacin;

MeSH definition : A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.;

MeSH synonym : 3-Pyridinecarboxylic Acid; nicotinic acid; 3 pyridinecarboxylic acid;

CISMeF synonym : acid, nicotinic;

MeSH hyponym : niacin hydrochloride; Niacin Aluminum Salt; induracin; Niacin Iron (2 ) Salt; nicocap; niacin tartrate; Niacin Cobalt (2 ) Salt; niacin tosylate; Niacin Sodium Salt; niacin zinc salt; Niacin Potassium Salt; Niacin Calcium Salt; Niacin Lithium Salt; nicobid; Niacin Manganese (2 ) Salt; lithium nicotinate; niacin lithium salt, hemihydrate; wampocap; nicamin; niacin ammonium salt; Niacin Magnesium Salt; Nico-400; nicolar; enduracin; niacin copper (2 ) salt; Potassium Salt, Niacin; Sodium Salt, Niacin; Tartrate, Niacin; Hydrochloride, Niacin; Tosylate, Niacin; Nico 400; Nico400; Nicotinate, Lithium; Aluminum Salt, Niacin;

Related MeSH term : nicotinate;

MeSH CAS label : 3-pyridinecarboxylic acid;

MeSH Related Number : niacin lithium salt, hemihydrate; niacin magnesium salt; niacin manganese (2 ) salt; niacin potassium salt; niacin sodium salt; niacin tartrate; niacin copper (2 ) salt; niacin hydrochloride; niacin iron (2 ) salt; niacin tosylate; niacin zinc salt; niacin aluminum salt; niacin ammonium salt; niacin calcium salt; niacin cobalt (2 ) salt; niacin lithium salt; 10361-13-4 (Fe(2 ) salt); 128758-69-0 (Li salt, hemi-H20); 16518-17-5 (K salt); 1976-28-9 (Al salt); 28029-53-0 (Co(2 ) salt); 28029-54-1 (Mn(2 ) salt); 30827-46-4 (Cu(2 ) salt); 36321-41-2 (NH4 salt); 3789-96-6 (tartrate); 51914-60-4 (Zn salt); 53890-72-5 (Li salt); 54-86-4 (Na salt); 636-79-3 (HCl); 7069-06-9 (Mg salt); 823-77-8 (Ca salt); 99148-57-9 (tosylate); 59-67-6;

Registry Number MeSH : 59-67-6;

Related CAS MeSH : 36321-41-2 (Niacin ammonium salt); 823-77-8 (Niacin calcium salt); 28029-53-0 (Niacin cobalt (2 ) salt); 53890-72-5 (Niacin lithium salt); 128758-69-0 (Niacin lithium salt, hemihydrate); 7069-06-9 (Niacin magnesium salt); 28029-54-1 (Niacin manganese (2 ) salt); 16518-17-5 (Niacin potassium salt); 54-86-4 (Niacin sodium salt); 3789-96-6 (Niacin tartrate); 30827-46-4 (Niacin copper (2 ) salt); 636-79-3 (Niacin hydrochloride); 10361-13-4 (Niacin iron (2 ) salt); 99148-57-9 (Niacin tosylate); 51914-60-4 (Niacin zinc salt); 1976-28-9 (Niacin aluminum salt);

MeSH annotation : /defic: consider also PELLAGRA; /ther use: coordinate with disease term with either /drug ther or /diet ther depending on whether niacin is discussed as a drug or a dietary supplement;

Wikipedia link : https://en.wikipedia.org/wiki/Niacin;

Codes EINECS : 200-441-0;

Is substance : O;

UNII : 2679MF687A;

Details


Main resources

You can consult :

A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.

http://www.cochrane.org/fr/CD009744/utilisation-de-la-niacine-chez-des-personnes-presentant-ou-non-une-maladie-cardio-vasculaire-etablie
2017
false
false
false
France
United Kingdom
French
french abstract
review of literature
niacin
cardiovascular diseases
niacin

---
http://www.health.belgium.be/fr/avis-9164-9174
http://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/css_9164_9174_avis_recommandations_nutritionnelles.pdf
2015
false
true
false
false
Belgium
French
recommended dietary allowances
public health guidelines
trace elements
vitamin A
vitamin D
infant, newborn
infant
child
adolescent
adult
aged
breast feeding
vitamin E
vitamin K
ascorbic acid
thiamine
riboflavin
niacinamide
niacin
pantothenic acid
vitamin B 6
pyridoxine
biotin
folic acid
vitamin B 12
iron
zinc
copper
selenium
iodine
manganese
molybdenum
chromium
fluorine
boron
silicon

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68267650
2012
France
summary of product characteristics
package leaflet
niacin
laropiprant
tablets

---
Pelzont - nicotinic acid / laropiprant
https://www.ema.europa.eu/medicines/human/EPAR/Pelzont
2012
false
United Kingdom
English
French
syndication feed
Primary hypercholesterolemia (disorder)
mixed dyslipidemia
pregnancy
breast feeding
treatment outcome
adult
aged
drug interactions
drug evaluation, preclinical
drug therapy, combination
hypercholesterolemia
niacin
indoles
dyslipidemias
hypolipidemic agents
drug combinations
niacin
indoles
hypolipidemic agents
administration, oral
tablets
drug approval
drug labeling
MK-0524
MK-0524
nicotinic acid, combinations
laropiprant
laropiprant
drug evaluation
summary of product characteristics
package leaflet

---
Tredaptive - nicotinic acid / laropiprant
This medicine is now withdrawn from use in the European Union
https://www.ema.europa.eu/medicines/human/EPAR/Tredaptive
2012
false
United Kingdom
English
French
syndication feed
Primary hypercholesterolemia (disorder)
mixed dyslipidemia
niacin
hypolipidemic agents
indoles
dyslipidemias
drug approval
drug labeling
treatment outcome
drug combinations
drug therapy, combination
indoles
hypolipidemic agents
niacin
tablets
administration, oral
hypercholesterolemia
adult
aged
drug interactions
breast feeding
drug evaluation, preclinical
MK-0524
MK-0524
nicotinic acid, combinations
laropiprant
laropiprant
drug evaluation
summary of product characteristics
package leaflet

---
Trevaclyn - nicotinic acid / laropiprant
https://www.ema.europa.eu/medicines/human/EPAR/Trevaclyn
2012
false
United Kingdom
French
English
syndication feed
Primary hypercholesterolemia (disorder)
mixed dyslipidemia
niacin
dyslipidemias
indoles
hypolipidemic agents
hypolipidemic agents
niacin
indoles
adult
aged
tablets
administration, oral
drug combinations
drug therapy, combination
drug interactions
drug approval
drug labeling
pregnancy
breast feeding
treatment outcome
hypercholesterolemia
MK-0524
MK-0524
nicotinic acid, combinations
laropiprant
laropiprant
drug evaluation
summary of product characteristics
package leaflet

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-11/tredaptive_-_ct-_8054.pdf
http://www.has-sante.fr/portail/jcms/c_1020473/tredaptive-acide-nicotinique-/-laropiprant-hypolipemiant
2010
France
French
Primary hypercholesterolemia (disorder)
drug combinations
niacin
administration, oral
MK-0524
indoles
nicotinic acid, combinations
insurance, health, reimbursement
hypolipidemic agents
Delayed-Action preparations
prostaglandin D2 receptor
receptors, immunologic
receptors, prostaglandin
dyslipidemias
treatment outcome
receptors, immunologic
receptors, prostaglandin
laropiprant
guidelines for drug use
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-11/tredaptive_-_ct-_8054.pdf
http://www.has-sante.fr/portail/jcms/c_1002687/tredaptive
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/tredaptive_ct_8054.pdf
2010
false
France
English
French
Primary hypercholesterolemia (disorder)
drug combinations
MK-0524
indoles
Delayed-Action preparations
administration, oral
niacin
hypolipidemic agents
insurance, health, reimbursement
dyslipidemias
receptors, prostaglandin
prostaglandin D2 receptor
receptors, immunologic
drug therapy, combination
adult
aged
treatment outcome
nicotinic acid, combinations
mixed dyslipidemia
evaluation of the transparency committee
receptors, immunologic
receptors, prostaglandin
laropiprant

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63416656
2010
false
France
French
Primary hypercholesterolemia (disorder)
mixed dyslipidemia
tablets
Delayed-Action preparations
niacin
niacin
drug therapy, combination
hypolipidemic agents
hypolipidemic agents
administration, oral
dyslipidemias
adult
aged
drug interactions
pregnancy
breast feeding
nicotinic acid
vitamin B complex
vitamin B complex
package leaflet
summary of product characteristics

---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Advicor(2)-Fr.pdf
2006
false
Canada
French
Primary hypercholesterolemia (disorder)
Product containing precisely lovastatin 20 milligram and nicotinic acid 1 gram/1 each conventional release oral tablet (clinical drug)
Product containing precisely lovastatin 20 milligram and nicotinic acid 500 milligram/1 each conventional release oral tablet (clinical drug)
mixed dyslipidemia
niacin
hypercholesterolemia
drug combinations
hypolipidemic agents
canada
lovastatin
dyslipidemias
lovastatin-niacin combination
lovastatin and nicotinic acid
lovastatin
niacin
drug evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_400245
2005
false
France
French
Primary hypercholesterolemia (disorder)
mixed dyslipidemia
Delayed-Action preparations
tablets
niacin
hypolipidemic agents
nicotinic acid
insurance, health, reimbursement
dyslipidemias
drug therapy, combination
adult
aged
treatment outcome
evaluation of the transparency committee

---
https://www.amub-ulb.be/system/files/rmb/old/192
2005
false
Belgium
French
Ezetimibe
hypolipidemic agents
fatty acids, Omega-3
piperidines
niacin
anticholesteremic agents
pyrazoles
docosahexaenoic acids
eicosapentaenoic acid
Omacor
drug combinations
journal article
Rimonabant

---
http://webprod.hc-sc.gc.ca/nhpid-bdipsn/monoReq.do?id=141&lang=fra
2004
Canada
French
niacin
niacin
niacin
nicotinic acid
monograph pharmacy

---
Nous contacter.
26/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.